Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-25
2010-11-16
Andres, Janet L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S119000
Reexamination Certificate
active
07834028
ABSTRACT:
The invention relates to novel pyrazolo-tetrahydropyridines compounds and their use as orexin receptor antagonists.
REFERENCES:
patent: 6703392 (2004-03-01), Aissaoui et al.
patent: 7192950 (2007-03-01), Aissaoui et al.
patent: 2004/0044031 (2004-03-01), Yamada et al.
patent: 2006/0178515 (2006-08-01), Aissaoui et al.
patent: 2007/0191424 (2007-08-01), Aissaoui et al.
patent: 2009/0082394 (2009-03-01), Jenck
patent: WO01/68609 (2001-09-01), None
patent: W02/051838 (2002-07-01), None
patent: WO03/091219 (2003-11-01), None
patent: WO2004/085403 (2004-10-01), None
patent: WO2005/118548 (2005-12-01), None
patent: WO2006/024779 (2006-03-01), None
Cai et. al., “Antagonists of the orexin receptors”, Expert Opinion Ther. Patents (2006) 16(5); pp. 631-646.
Aissaoui Hamed
Boss Christoph
Gude Markus
Koberstein Ralf
Sifferlen Thierry
Actelion Pharmaceuticals Ltd.
Andres Janet L
Hoxie & Associates LLC
Robinson Binta M
LandOfFree
Pyrazolo-tetrahydro pyridine derivatives as orexin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolo-tetrahydro pyridine derivatives as orexin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo-tetrahydro pyridine derivatives as orexin receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4184570